title: Synergistic antifibrotic effect of verapamil and interferon-gamma in rats: partially based on enhanced verapamil oral bioavailability.
authors.affiliation: Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.
authors.forename: Dan
authors.initials: D
authors.lastname: Xu
authors.forename: Man
authors.initials: M
authors.lastname: Chen
authors.forename: Yu
authors.initials: Y
authors.lastname: Guo
authors.forename: Gai
authors.initials: G
authors.lastname: Liang
authors.forename: Benjian
authors.initials: B
authors.lastname: Zhang
authors.forename: Jingquan
authors.initials: J
authors.lastname: Tan
authors.forename: Jacques
authors.initials: J
authors.lastname: Magdalou
authors.forename: Hui
authors.initials: H
authors.lastname: Wang
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019540:Area Under Curve; D001682:Biological Availability; D002121:Calcium Channel Blockers / Q000493:pharmacokinetics / Q000627:therapeutic use*; D051544:Cytochrome P-450 CYP3A / Q000187:drug effects; D004357:Drug Synergism; D007371:Interferon-gamma / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008106:Liver Cirrhosis, Experimental / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D016896:Treatment Outcome; D014700:Verapamil / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D002121:Calcium Channel Blockers; D007371:Interferon-gamma; D014700:Verapamil; D051544:Cytochrome P-450 CYP3A